Thomas Grenkowitz

Statistics

Publications

Citations

235

H-Index

Active since

2015

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

Synlab (Germany)

University Hospital Heidelberg

Freie Universität Berlin

Thomas Grenkowitz is an author at Charité - Universitätsmedizin Berlin specializing in molecular genetics, medical genetics, and pcsk9 inhibitor therapy.

ORCID

Publications per year

2015–2021

Publications

Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia

Thomas Grenkowitz, Ursula Kassner, Marion Wühle-Demuth et al. · Atherosclerosis · 2016 · 45 citations

Medicine, Genetics, Molecular Genetics +17

Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions

Ursula Kassner, Tim Hollstein, Thomas Grenkowitz et al. · Human Gene Therapy · 2018 · 36 citations

Life Sciences, Biochemistry, Molecular Genetics +17

Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study

Tim Hollstein, Anja Vogt, Thomas Grenkowitz et al. · Vascular Pharmacology · 2019 · 36 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors

Valentin Blanchard, Kévin Chemello, Tim Hollstein et al. · Cardiovascular Research · 2021 · 30 citations

Life Sciences, Biochemistry, Pharmacology +15

Evaluation of the role of STAP1 in Familial Hypercholesterolemia

Magdalena Danyel, Claus‐Eric Ott, Thomas Grenkowitz et al. · Scientific Reports · 2019 · 23 citations · Full text

Medicine, Genetics, Molecular Genetics +17

1–5 of 9